Real-world data analysis of the clinical and economic burden and risk factors in patients with major depressive disorder with an inadequate response to initial antidepressants-Reference-Cited by-同舟云学术

Real-world data analysis of the clinical and economic burden and risk factors in patients with major depressive disorder with an inadequate response to initial antidepressants

Published:2021-01-01 Issue:1 Volume:24 Page:589-597
ISSN:1369-6998
Container-title:Journal of Medical Economics
language:en
Short-container-title:Journal of Medical Economics

Author:

Park HyeJin¹^ORCID,Park Chan Mi²^ORCID,Woo Jong-Min³^ORCID,Shin Ju-Young¹^ORCID,Lee Eui-Kyung¹^ORCID,Kwon Sun-Hong¹^ORCID

Affiliation:

1. School of Pharmacy, Sungkyunkwan University, Gyeonggi-do, Republic of Korea

2. National Evidence-based Healthcare Collaborating Agency, Seoul, Republic of Korea

3. Hanbyul Psychiatric Hospital, Gyeonggi-do, Republic of Korea

Publisher

Informa UK Limited

Subject

Health Policy

Link

https://www.tandfonline.com/doi/pdf/10.1080/13696998.2021.1918922

Reference32 articles.

1. Cross-national epidemiology of DSM-IV major depressive episode

2. A Review of the Clinical, Economic, and Societal Burden of Treatment-Resistant Depression: 1996–2013

3. Acute and Longer-Term Outcomes in Depressed Outpatients Requiring One or Several Treatment Steps: A STAR*D Report

4. Treatment-resistant depression: Definitions, review of the evidence, and algorithmic approach

5. Definition of treatment-resistant depression – Asia Pacific perspectives

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Genetic Correlates of Treatment-Resistant Depression: Insights from Polygenic Scores Across Cognitive, Temperamental, and Sleep Traits in the All of US cohort;2024-07-05

2. Treatment-Resistant Depression in America Latina study: one-year follow-up of treatment resistant depression patients under standard of care reveals insights on quality of life, disability, work impairment, and depressive symptoms;Frontiers in Psychiatry;2023-10-27

3. Integrated Module of Multidimensional Omics for Peripheral Biomarkers (iMORE) in patients with major depressive disorder: rationale and design of a prospective multicentre cohort study;BMJ Open;2022-11

4. Recommendations of the treatment-resistant depression expert center network for promoting tobacco smoking cessation based on the results from the real-world FACE-TRD national cohort;Progress in Neuro-Psychopharmacology and Biological Psychiatry;2022-03

5. Incidence of Depression after Traumatic Brain Injury: A Nationwide Longitudinal Study of 2.2 Million Adults;Journal of Neurotrauma;2022-02-02